Niti Aayog working on blockchain tech for drug industry

Image
Press Trust of India Hyderabad
Last Updated : Aug 03 2018 | 5:50 PM IST

Niti Aayog is working with Apollo Hospitals and information technology major Oracle on applying blockchain (decentralised) technology in pharmaceutical supply chain management to detect spurious drugs, Chief Executive Officer of NITI Aayog Amitabh Kant said here today.

Addressing a gathering through video-conferencing at the inaugural session of International Blockchain Congress 2018 for which Niti Aayog was a co-host, Kant said the organisation was working on applying the blockchain technology to pressing problems of the country in areas such as land registry, health records and fertiliser subsidy distribution m among others.

"There is a need to use blockchain to track and trace medicines and spurious drugs. Therefore, Niti Aayog, in collaboration with Apollo Hospitals and Oracle, is putting pharmaceutical supply chain in blockchain for complete traceability of drugs from manufacturer to consumer to protect our citizens from the menace of spuriousmedicines, he said.

The agency was working with judiciary too to see the civil cases related to land registration and mutation were expedited, he said.

"The government has to play a leading role in allowing the application of blockchain technology. As the government, we need to make it easier to apply blockchain in pressing areas such as disbursement, land records, health records. Countries around the world had to improve and change the legal system to make themselves use blockchain technology," Kant said.

Emerging technologies such as blockchain technology were key drivers for ease of doing business and were essential for a free market, he added.

State Minister for IT and Industries KT Ramarao, Tech Mahindra Chief Executive Officer CP Gurnani and CEO of Nucleus Vision Abhishek Pitti also spoke.

The valedictory function of the International Blockchain Congress would be held in Goa on August 5.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 03 2018 | 5:50 PM IST

Next Story